Bioinformatics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Bioinformatics Market is segmented by Products and Services, Application (Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics and Other Applications), and Geography

Market Snapshot

Study Period:


Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America


20.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The propelling factors for the growth of the global bioinformatics market include the increasing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, accelerating growth of proteomics and genomics, and increasing research on molecular biology and drug discovery. Owing to the aforementioned factors, the global bioinformatics market is expected to experience a boost during the forecast period.

Bioinformatics is gaining importance, as large amounts of data generated through techniques, like nucleic acid and protein sequencing, require data management and interpretation for future researches and medical purposes. Hence, increasing demand is expected to drive the bioinformatics market during the forecast period.

The demand for differentially expressed genes, computational epigenetics, meta-analysis of microarray data, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market.

There is also little research that has been done in the field of bioinformatics to expedite decision-making in healthcare. Within clinical or medical informatics, there is a rich history of research on systems designed to help care providers and patients (healthcare consumers) and make optimal decisions surrounding diagnosis and management.

Scope of the Report

As per the scope of the report, bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information and is applied to gene-based drug discovery and development, protein structure studies, and the determination of the therapeutic efficacy of drugs.

By Product and Services
Knowledge Management Tools
Bioinformatics Platform
Sequence Analysis Platform
Sequence Alignment Platform
Sequence Manipulation Platform
Structural and Functional Analysis Platform
Other Bioinformatics Platforms
Bioinformatics Services
Sequencing Services
Database and Management Services
Data Analysis
Other Bioinformatics Services
By Application
Microbial Genome
Gene Engineering
Drug Development
Personalized Medicine
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period

  • Personalized medicine has used translational bioinformatics mostly to analyze the development of storage, analytical, and interpretive methods, so as to optimize the transformations of increasing voluminous biomedical data.
  • Developments in pharmacogenomics and systems biology have helped personalized medicine to change from reductionism-based and disease-centered medical practice to system-based, integrative, and human-centered care.
  • Bioinformatics is an essential component in basic research and in the development of new concepts for diagnosis and therapy, as well as in clinical practice, in which these concepts are applied to treat patients. Some of the major drivers that help in the increasing demand for bioinformatics are, growing applications of bioinformatics in drug discovery and development and growing bioinformatics support in the development of personalized medicines and clinical diagnostics.

To understand key trends, Download Sample Report

Asia-Pacific Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

A large number of healthcare investments in the Asia-Pacific region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including China and India, are expected to propel the bioinformatics market in this region mainly. 

In the north america region united states is expected to hold the major share, and this is mainly due the factors such as United States contributes majorly to the research being done in the fields of drug discovery, genomics, and proteomics structure prediction, among others, in the region, thereby boosting the growth of the bioinformatics market. A rapid expansion in pharmaceutical science, agrobiotechnology, microbial genomics, and personalized medicine has also raised revenues for the use of bioinformatics tools.

To understand geography trends, Download Sample Report.

Competitive Landscape

Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others. 

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing

      2. 4.2.2 Increasing Initiatives from Governments and Private Organizations

      3. 4.2.3 Accelerating Growth of Proteomics and Genomics

      4. 4.2.4 Increasing Research on Molecular Biology and Drug Discovery

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data

      2. 4.3.2 Data Complexity Concerns and Lack of User-friendly Tools

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product and Services

      1. 5.1.1 Knowledge Management Tools

      2. 5.1.2 Bioinformatics Platform

        1. Sequence Analysis Platform

        2. Sequence Alignment Platform

        3. Sequence Manipulation Platform

        4. Structural and Functional Analysis Platform

        5. Other Bioinformatics Platforms

      3. 5.1.3 Bioinformatics Services

        1. Sequencing Services

        2. Database and Management Services

        3. Data Analysis

        4. Other Bioinformatics Services

    2. 5.2 By Application

      1. 5.2.1 Microbial Genome

      2. 5.2.2 Gene Engineering

      3. 5.2.3 Drug Development

      4. 5.2.4 Omics

      5. 5.2.5 Personalized Medicine

      6. 5.2.6 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Illumina Inc.

      2. 6.1.2 Thermo Fischer Scientific (Life Technologies)

      3. 6.1.3 Qiagen NV

      4. 6.1.4 Agilent Technologies

      5. 6.1.5 PerkinElmer

      6. 6.1.6 ABM

      7. 6.1.7 Dassault Systèmes

      8. 6.1.8 Geneva Bioinformatics SA

      9. 6.1.9 Ontoforce

      10. 6.1.10 Data4Cure

      11. 6.1.11 Lineage Cell Therapeutics (BioTime Inc.)

  7. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports